Central America vs Qatar: Proportion of the target population who received a 3rd dose of
Central America
80.0%
in 2024
Qatar
96.0%
in 2024
Central America rank
13th
Qatar rank
16th
Proportion of the target population who received a 3rd dose of over time
- Central America
- Qatar
How they compare
Qatar currently reports 96.0% against 80.0% in Central America, a difference of 16.0%.
That makes Qatar's figure about 1.2 times Central America's.
Across all 16 years both countries report, Qatar has been ahead every year.
Central America ranks 13th and Qatar ranks 16th of 37 groups.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central America | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 99.0% | 66.0% | Qatar |
| 2010s | 86.5% | 96.6% | 10.1% | Qatar |
| 2020s | 81.4% | 97.2% | 15.8% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central America or Qatar?
- Qatar, at 96.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central America and Qatar?
- 16.0%, with Qatar ahead.
- How many years of comparable data are there for Central America and Qatar?
- 16 years are reported by both, from 2009 to 2024.
- How do Central America and Qatar rank globally for proportion of the target population who received a 3rd dose of?
- Central America ranks 13th and Qatar ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.